BREAKING NEWS: UW Sold Fetal Brains to Indiana University, Still Blocking Release of Public Records

The University of Washington’s Birth Defects Research Laboratory (UWBDRL) sold brains from aborted babies for $200 each to Indiana University, according to an invoice recently uncovered by Indiana Right to Life.

The invoice, dated July 25, 2013, records the sale of two shipments of brain tissue.

The Birth Defects Research Laboratory at the University of Washington often acted as a middleman between abortion clinics and medical researchers, securing aborted fetal tissue from Planned Parenthood and other abortion clinics in Washington State that it then sold to other medical researchers across the nation.

Some critics have questioned whether UWBDRL violated federal human trafficking laws that prohibit the sale of fetal tissue.

The recently released invoice showing UWBDRL’s sale of aborted fetal tissue to Indiana University is concerning, especially since there are questions still remaining about UWBDRL’s business arrangement with Planned Parenthood clinics in Washington State.

When Zach Freeman, FPIW’s Communications Director, filed a public records request soliciting the business agreement between Planned Parenthood and UWBDRL, Planned Parenthood sued, effectively delaying the release of the business agreement indefinitely.

Without the business agreement, which is not being made public because of Planned Parenthood’s ongoing federal lawsuit, we cannot know whether UWBDRL engaged in illegally selling aborted fetal tissue. Since UWBDRL is a public entity, the public deserves to know the extent of UWBDRL’s relationship with Planned Parenthood, as well as whether any laws regarding trafficking aborted fetal tissue were violated.

Click here to contribute to the legal fund.

Trump Taps Rep. Tom Price, Pro-Life Doctor, for HHS Secretary

President-elect Donald Trump has selected pro-life champion Rep. Tom Price (R-GA) to run the Department of Health and Human Services.

Price, a physician, is a known opponent of Obamacare, signaling the incoming administration’s intention of following through with its campaign promise to “repeal and replace.”

“Some Republicans have attacked the Affordable Care Act without proposing an alternative,” reported the New York Times. “Mr. Price, by contrast, has introduced bills offering a detailed, comprehensive replacement plan in every Congress since 2009, when Democrats started work on the legislation.”

Price’s piece of legislation, the Empowering Patients First Act, would repeal and replace Obamacare and create tax credits for the purchase of individual and family health insurance policies.  If passed, it would also create new incentives for people to contribute to health savings accounts, offer grants to states to subsidize insurance for “high-risk populations,” and promote competition by allowing insurers to sell policies across state lines.  His legislation also provides explicit protections for religious freedom and rights of conscience related to the practice of abortion and the dispensing of abortion-inducing drugs.

As an added bonus, Price has consistently — 100% of the time — voted to Defund Planned Parenthood.  He is an outspoken critic of abortion, calling it a “barbaric” practice.

Planned Parenthood and pro-choice advocacy group NARAL seems concerned by the selection as well:

Price has been strong on all of FPIW’s issues in Congress, stating after the Supreme Court’s ruling on same-sex marriage that it was “not only a sad day for marriage, but a further judicial destruction of our entire system of checks and balances.”

Price must be confirmed by the incoming U.S. Senate next year before taking over the Department.  And of course, if confirmed, he would no longer be a member of Congress, meaning that his legislation would have to be picked up by another member of Congress. But with conservative majorities in the House and Senate, and a clear priority for the incoming Trump Administration to repeal and replace Obamacare, we don’t expect finding legislative sponsors to be an issue.

We’ll keep you updated through the confirmation process.  Follow us on Facebook and Twitter!